deltatrials
Recruiting PHASE1 INTERVENTIONAL 2-arm NCT07212868

The Role of Glucagon in Glucose Metabolism in Humans With and Without Bariatric Surgery

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Conditions Non-Diabetic
Interventions Exogenous glucagon versus saline infusion REMD-477 versus Placebo
Updated 4 times since 2025 Last updated: Mar 9, 2026 Started: Feb 25, 2026 Primary completion: May 1, 2030 Completion: Jun 30, 2030
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Non-Diabetic, this trial is actively recruiting participants. The trial is conducted by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and has accumulated 4 data snapshots since 2026. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Nov 2025 – ~Dec 2025 · 30 days · monthly snapshotNot Yet Recruiting~Dec 2025 – ~Jan 2026 · 31 days · monthly snapshotNot Yet Recruiting~Jan 2026 – ~Mar 2026 · 59 days · monthly snapshotNot Yet Recruiting~Mar 2026 – present · 4 months · monthly snapshotRecruiting

Change History

4 versions recorded

  1. Mar 2026 — Present [monthly]

    Recruiting PHASE1

    Status: Not Yet Recruiting → Recruiting

  2. Jan 2026 — Mar 2026 [monthly]

    Not Yet Recruiting PHASE1

  3. Dec 2025 — Jan 2026 [monthly]

    Not Yet Recruiting PHASE1

  4. Nov 2025 — Dec 2025 [monthly]

    Not Yet Recruiting PHASE1

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
  • The University of Texas Health Science Center at San Antonio
Data source: The University of Texas Health Science Center at San Antonio

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations